Skip to Main Content
Phase COVID-Pilot

Perinatal Attentional Retraining Intervention for Smoking (PARIS)

  • Study HIC#:1008007245
  • Last Updated:08/20/2021

Brief Summary:

The proposed research intends to randomize 50 abstinent pregnant smokers to receive either the attentional retraining (AR) or control VP task. Participants will be asked to carry around a smartphone as they go about their daily lives for 2 weeks in their last month of pregnancy (Phase 1).

The smartphone will sound an alert randomly during the day, at which time participants will be asked to respond to a short set of questions assessing subjective states; this will be followed by a request to complete the AR (or control) procedures. This same procedure will be repeated for 2 weeks immediately after delivery (Phase 2).

Women will undergo a follow-up visit 3 months after the end of Phase 2, and complete an unmodified VP and follow-up assessments.

  • Age18 years - 40 years
  • GenderFemale only
  • Start Date08/25/2010
  • End Date09/30/2022

Trial Purpose and Description

The purpose of the study is to examine the relapse process in postpartum smokers using Ecologicl Momentary Assessment and to determine the impact of situational and affective stimuli on relapse in the postpartum period.

Eligibility Criteria

Inclusion Criteria:

  • Women with a history of smoking 5+ cigarettes per day that have achieved abstinence during pregnancy by 32 weeks gestation.
  • The ability to speak and write English.
  • An Edinburgh Postnatal Depression Scale (EPDS) score <10.

Exclusion Criteria:

  • Current substance abuse (e.g., alcohol, benzodiazepines, marijuana).
  • Current major depressive disorder, minor depression or dysthymia, or history of any of these disorders in the last 6 months.
  • The presence of an Axis I psychotic disorder.
  • Plans to relocate out of the area.
  • Imminent incarceration.
  • Planned inpatient hospitalization during study period.
  • Plans to breastfeed. Women who plan to breastfeed will be excluded since this is a powerful, independent motivation for remaining abstinent and may decrease the relapse event rate.

Sub-Investigators

For more information about this study, contact:

Or contact the Help us Discover team on: